Collaboration Committee. 3.1. Enterprises covered by this Agreement shall have an active collaboration committee of the enterprise and the employees. This committee shall consist of two representatives from the employer and two employee representatives.
Collaboration Committee. The Parties shall establish a Collaboration Committee to oversee, review and coordinate the conduct of the Collaboration. The Collaboration Committee shall be comprised of three (3) representatives from each of SPL and Pharmacopeia, or such other equal number of representatives as the Parties may agree, each Party’s members selected by that Party. Each of Pharmacopeia and SPL may replace its Collaboration Committee representatives at any time upon written notice to the other Party. The Collaboration Committee shall be chaired by the Collaboration Director appointed by SPL, unless otherwise agreed by the Parties. From time to time the Collaboration Committee may establish various subcommittees, constituted as agreed by the Collaboration Committee, to oversee particular projects or activities within the Collaboration.
Collaboration Committee. 7.1 The Parties shall establish a Collaboration Committee to oversee the implementation of the Program. The Collaboration Committee will consist of four (4) members, each Party to appoint two (2) members. The Collaboration Committee will meet monthly by teleconference and quarterly at ICS.
Collaboration Committee. 9 2.1.1 Responsibilities. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 2.1.2 Membership. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 2.1.3 Meetings. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 2.1.4 CC Decisions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 2.2
Collaboration Committee. In an effort to maintain open communication and cooperation, the parties agree to meet informally at least once each month to discuss issues of mutual concern. Issues for consideration may be raised by any party. It is expected that concerns or questions should first be processed through regular channels between employees and the appropriate supervisor. If that fails to completely resolve the question, then this matter can be presented to this committee. Issues will be addressed in the monthly meeting with up to the following seven persons representing the Association: the CESA President(s), and five other members appointed by the Association. In no case do these parties have the power to alter the terms or the intent of the collective bargaining agreement.
Collaboration Committee. Upon such notice, AVI and SuperGen shall form a International Collaboration Committee to oversee and coordinate a strategy for developing, commercializing and distributing the Product in the International Territory. The International Collaboration Committee shall consist of no more than four (4) total members, with two representatives from each Party.
Collaboration Committee. The Parties shall establish a committee (the “Collaboration Committee”), alternately chaired by Clearside SANTEN, with Clearside chairing the first meeting, SANTEN chairing the next meeting so on. The Collaboration Committee shall consist of up to two (2) members from each Party, provided, however, that additional representatives from either Party may participate in the meeting depending CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE COPY FILED HEREWITH OMITS THE INFORMATION SUBJECT TO A CONFIDENTIALITY REQUEST. OMISSIONS ARE DESIGNATED [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. on the agenda as appropriately required for a meaningful contribution to the meeting. The chairperson’s duties shall include site selection (if applicable), agenda and facilitation; provided however, that a non-chairing Party’s committee member may submit agenda items to the chairperson and such items may be included in the next regular meeting of the Collaboration Committee at the chairperson’s reasonable discretion. The Collaboration Committee shall meet in person or via tele-conference each calendar month or otherwise at the call of the chairperson to review, coordinate, and discuss the progress, issues and disputes regarding the Collaboration Program.
Collaboration Committee. Promptly after the Effective Date, the parties shall establish a committee with the duties and responsibilities set forth in this Agreement that shall be comprised of personnel from Focal and Genzyme (the "Collaboration Committee"). The Collaboration Committee shall include four (4) voting members, two (2) of whom shall be appointed by Genzyme and two (2) of whom shall be appointed by Focal. Each party shall make its designation of its initial representatives not later than fifteen (15) days after the Effective Date. Each party shall use reasonable efforts to designate as its representatives, individuals that shall have the requisite experience and knowledge to oversee the commercialization activities contemplated by this Agreement. Vacancies on the Collaboration Committee shall be filled within ten (10) days after the date such vacancy occurs. In addition, each party may designate any number of additional persons to serve as advisors to the Collaboration Committee. Each party shall designate its members to the Collaboration Committee, and shall notify the other party in writing each time it permanently replaces and appoints a new designated member. If a member of the Collaboration Committee is unable to attend a meeting, the party that appointed such member may designate a substitute to participate in lieu of the absent member. One member of the Collaboration Committee shall be elected by the Collaboration Committee to serve as its Chairman for any term approved by the Collaboration Committee. The Chairman shall preside at all meetings of the Collaboration Committee, shall prepare the agenda for each meeting, shall cause minutes of each meeting to be taken and shall maintain the records of the Collaboration Committee. There shall be no limit on the number of alternate or successive terms that a member may serve as Chairman.
Collaboration Committee. 20 6.1.1 Formation......................................................20 6.1.2 Duties of the Collaboration Committee..........................20 6.2
Collaboration Committee. The Parties have established a Collaboration Committee to ensure coordination, information-sharing and common understanding amongst the Parties, and serve as a forum for brainstorming and strategizing. The Collaboration Committee will serve as the primary venue for coordinating amongst the Parties on the implementation of this Relationship Agreement. Each member of the Collaboration Committee is responsible for reporting to and taking direction from their respective organization with respect to the operations of the Committee. Governance Function FNHC MANDATE FNHA MANDATE The FNHC is a political and advocacy organization, representative of and accountable to BC First Nations, with the following mandate: • Dedicated political leadership for the implementation of the Health Plans • Provide continued political leadership for implementation of the TCA: FNHP and TFNHP • Reflect a philosophy and culture of trust, unity, honesty, humility, healthy living, traditional practices and teachings in operations, planning and decision-making • Support to First Nations in achieving their health priorities and objectives • Support Community-Driven and Nation- Based approaches • Promote individual health and wellness responsibilities, including self-care and health literacy • Promote the transfer of health services to local and regional levels wherever possible, practical and feasible • Health Advocacy and Relationships • Health advocacy, knowledge sharing and collaboration with government partners and others at the highest levels (including internationally) • Advocacy for service improvements for First Nations • Provide a BC First Nations leadership perspective to research, policy and program planning processes related to First Nations health in BC • Develop relationships and alliances with other First Nations organizations, government Ministries and Departments, and others, to achieve progress in the social determinants of health • Politically oversee the transition of FNIH to a new First Nations Health Authority • Promote and ensure communication, transparency, cost-effectiveness and accountability of the FNHC to First Nations • Operate to a good governance standard including having an approved and transparent Terms of Reference; transparent processes; active, participatory members; cost-efficiency; professionalism; regular accountability and reporting; on-going evaluation of the role and benefit of the FNHC • Develop and implement a robust and sustainable communications...
